Publications

Refereed Papers in Professional Journals

Basic Research

  1. Khoury EE , Kinaneh S, Aronson D, Amir O, Ghanim D, Volinsky N, Azzam Z, Abassi Z. Natriuretic Peptides System in the Pulmonary Tissue of Rats with Heart Failure: Potential Involvement in Lung Edema and Inflammation. Oncotarget, 2018, Vol. 9, (No. 31), pp: 21715-21730. PMID: 29774097 PMCID: PMC5955134 DOI: 10.18632/oncotarget.24922
  2. Heyman SN, Abassi Z, Rosenberger C, Yaseen H, Skarjinski G, Shina A, Mathia S, Krits N, Khamaisi M. Cyclosporine A induces endothelin-converting enzyme-1: Studies in vivo and in vitro. Acta Physiol (Oxf). 2018 Jan 13. doi: 10.1111/apha.13033. PMID: 29330945 DOI: 10.1111/apha.13033
  3. Khamaysi I., Singh P., Nasser S., Awad H., Chowers Y., Sabo E., Hammond E.,  Gralnek I.,    Minkov  Noseda A.,  Ilan N.,  Vlodavsky I., Abassi Z. The Role of Heparanase in the Pathogenesis of Acute Pancreatitis: A Potential Therapeutic Target. Sci Rep.;7(1):715, 2017. PMID: 28386074 PMCID: PMC5429646 DOI: 10.1038/s41598-017-00715-6
  4. Abassi Z., Hamoud S., Hassan A., Khamaysi I , Nativ O, Heyman S. N., Shekh Muhammad R., Ilan N., Singh P., Hammond E., Zaza G., Lupo A., Onisto M., Bellin G., Masola V., Vlodavsky I. and Gambaro G. Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. Oncotarget.;8(21):34191-34204, 2017. PMID: 28388547 PMCID: PMC5470960 DOI: 10.18632/oncotarget.16573
  5. Ariel I, Skarzinski G, Belzer V, Abu Ahmad W, Abassi Z, Bursztyn M. Vasoactivity of the rat endovascular trophoblast. Placenta. 46:26-30, 2016. PMID: 27697218 DOI: 10.1016/j.placenta.2016.08.077
  6. Masola V, Zaza G, Gambaro G, Onisto M, Bellin G, Vischini G, Khamaysi I, Hassan A, Hamoud S, Nativ O, N Heyman S, Lupo A, Vlodavsky I, Abassi Z. Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. PLoS One. 11(7):e0160074, 2016. PMID: 28394941 PMCID: PMC5386272 DOI: 10.1371/journal.pone.0175618
  7. Gil A, Brod V, Awad H, Heyman SN, Abassi Z, Frajewicki V. Neutrophil gelatinase-associated lipocalin in a triphasic rat model of adenine-induced kidney injury. Ren Fail. 13:1-7, 2016. PMID: 27291966 DOI: 10.1080/0886022X.2016.1194164
  8. Ismael-Badarneh R, Guetta J, Klorin G, Berger G, Abu-Saleh N, Abassi Z, Azzam ZS. The Role of Angiotensin II and Cyclic AMP in Alveolar Active Sodium Transport. PLoS One. 10(7):e0134175, 2015. PMID: 26230832 PMCID: PMC4521808 DOI: 10.1371/journal.pone.0134175
  9. Lahoud Y, Hussein O, Shalabi A, Nativ O, Awad H, Khamaisi M, Matar I, Nativ O, Abassi Z. Effects of phosphodiesterase-5 inhibitor on ischemic kidney injury during nephron sparing surgery: quantitative assessment by NGAL and KIM-1. World J Urol. 33:2053-62, 2015. PMID: 25981401 DOI: 10.1007/s00345-015-1579-3
  10. Malka A, Meerkin D, Barac YD, Malits E, Bachner-Hinenzon N, Carasso S, Ertracht O, Angel I, Shofti R, Youdim M, Abassi Z, Binah O. TVP1022: a novel cardioprotective drug attenuates left ventricular remodeling following ischemia/reperfusion in pigs. J Cardiovasc Pharmacol. 66:214-22, 2015. PMID: 25900266 DOI: 10.1097/FJC.0000000000000267
  11. Assady S, Alter J, Axelman E, Zohar Y, Sabo E, Litvak M, Kaplan M, Ilan N, Vlodavsky I, Abassi Z. Nephroprotective Effect of Heparanase in Experimental Nephrotic Syndrome. PLoS One.;10(3):e0119610, 2015. PMID: 25786136 PMCID: PMC4364762 DOI: 10.1371/journal.pone.0119610
  12. Cohen-Segev R, Francis B, Abu-Saleh N, Awad H, Lazarovich A, Kabala A, Aronson D, Abassi Z. Cardiac and renal distribution of ACE and ACE-2 in rats with heart failure. Acta Histochem. 116(8):1342-9, 2014. PMID: 25217176 DOI: 10.1016/j.acthis.2014.08.006
  13. Ariel I, Skarzinski G, Kossovsky T, Belzer V, Knigin D, Khamaisi M, Abassi Z, Bursztyn M. Ex vivo endothelin dependent contraction of the remodeled rat spiral artery. Placenta. 35(9):702-8, 2014. PMID: 25064069 DOI: 10.1016/j.placenta.2014.07.005
  14. Nakhleh MK, Amal H, Awad H, Gharra A, Abu-Saleh N, Jeries R, Haick H, Abassi Z. Sensor arrays based on nanoparticles for early detection of kidney injury by breath samples. Nanomedicine. 10(8):1767-76, 2014. PMID: 24954383 DOI: 10.1016/j.nano.2014.06.007
  15. Hoffman A, Okun-Gurevich M, Ovcharenko E, Goltsman I, Karram T, Cain C, Abassi Z, Winaver J. Renal effects of a novel endogenous natriuretic agent xanthurenic acid 8-o-β-d-glucoside in rats. Physiol Rep1(6):e00155, 2013. PMID: 24400157 PMCID: PMC3871470 DOI: 10.1002/phy2.155
  16. Abassi Z, Okun-Gurevich M, Abu Salah N, Awad H, Mandel Y, Campino G, Mahajna A, Feuerstein GZ, Fitzpatrick M, Hoffman A, Winaver J.  Potential early predictors for outcomes of experimental hemorrhagic shock induced by uncontrolled internal bleeding in rats. PLoS One. 26;8(11):e80862, 2013. PMID: 24303027 PMCID: PMC3841163 DOI: 10.1371/journal.pone.0080862
  17. Abu Saleh N, Awad H, Khamaisi M, Armaly Z, Karram T, Heyman SN, Kaballa A, Ichimura T, Holman J, Abassi Z. Nephroprotective Effects of TVP1022, a non-MAO inhibitor S-Isomer of Rasagiline, in Experimental Model of Diabetic Renal Ischemic Injury. Am J Physiol Renal Physiol.;306(1):F24-33, 2014. PMID: 24197064 DOI: 10.1152/ajprenal.00379.2013
  18. Abassi Z, Weissman I, Karram T, Goltsman I, Hoffman A, Better OS, Winaver J. Restoration of Renal Responsiveness to Atrial Natriuretic Peptide in Experimental Nephrotic Syndrome by Albumin Infusion. Am J Nephrol. 23;38(4):292-299, 2013. PMID: 24080549 DOI: 10.1159/000355014
  19. Assady S, Marom O, Hemli M, Ionescu R, Jeries R, Tisch U, Abassi Z, Haick H. Impact of hemodialysis on exhaled volatile organic compounds in end-stage renal disease: a pilot study. Nanomedicine (Lond). 9(7):1035-45, 2014. PMID: 24066923 DOI: 10.2217/nnm.13.85
  20. Alcalay Y, Hochhauser E, Kliminski V, Dick J, Zahalka MA, Parnes D, Schlesinger H, Abassi Z, Shainberg A, Schindler RF, Brand T, Kessler-Icekson G. Popeye domain containing 1 (popdc1/bves) is a caveolae-associated protein involved in ischemia tolerance. PLoS One. 16;8(9):e71100, 2013. PMID: 24066022 PMCID: PMC3774711 DOI: 10.1371/journal.pone.0071100
  21. Aronson D, Abassi Z, Allon E, Burger AJ. Fluid loss, venous congestion, and worsening renal function in acute decompensated heart failure. Eur J Heart Fail. 15(6):637-43, 2013. PMID: 23475780 DOI: 10.1093/eurjhf/hft036
  22. Shalabi A, Abassi Z, Awad H, Halachmi S, Moskovitz B, Kluger Y, Nativ O. Urinary NGAL and KIM-1: potential association with histopathologic features in patients with renal cell carcinoma. World J Urol. 31(6):1541-5, 2013. PMID: 23430218 DOI: 10.1007/s00345-013-1043-1
  23. Sohotnik R, Nativ O, Abbasi A, Awad H, Frajewicki V, Bishara B, Sukhotnik I, Armaly Z, Aronson D, Heyman SN, Nativ O, Abassi Z. Phosphodiesterase5 Inhibition Attenuates Early Renal Ischemia/Reperfusion-Induced Acute Kidney Injury: Assessment by measurement of urinary NGAL and KIM-1. Am J Physiol: Renal Physiol. 15;304:F1099-104, 2013. PMID: 23364806 DOI: 10.1152/ajprenal.00649.2012
  24. Naffaa M, Abu-Saleh N, Awad H, Khamaysi I, Karram T, Azzam ZS, Abassi Z, Bishara B. Acute obstructive jaundice and chronic cirrhosis protect against the adverse renal effects of pneumoperitoneum: role of nitric oxide. Surg Endosc. 27(7):2517-25, 2013. PMID: 23355167 DOI: 10.1007/s00464-012-2773-7
  25. Abassi Z., Shalabi A., Sohotnik R., Nativ O., Awad H., Bishara B., Frajewicki V., Sukhotnik I., Abbasi A., and Nativ O. Urinary NGAL and KIM-1: Biomarkers for Assessment of Acute Ischemic Kidney Injury Following Nephron Sparing Surgery. J Urol. 189(4):1559-66, 2013. PMID: 23085062 DOI: 10.1016/j.juro.2012.10.029
  26. Guetta J., Klorin G., Tal R., Berger G., Ismael-Badarneh R., Bishara B., Sabo E., Abassi Z., and Azzam ZS. Vasopressin-2 Receptor Antagonist Attenuates the Ability of the Lungs to Clear Edema. American Journal of Respiratory Cell and Molecular Biology, 47(5):583-8, 2012. PMID: 22700868 DOI: 10.1165/rcmb.2012-0117OC
  27. Bishara B., Abu-Saleh N., Awad H., Ghrayeb N., Goltsman I., Aronson D., Khamaysi I., Assady I., Armaly Z., Haddad S., Haddad E., and Abassi Z. Phosphodiesterase 5 Inhibition Protects Against Increased Intra-abdominal Pressure-Induced Renal Dysfunction in Experimental Congestive Heart Failure. Euro J Heart Fail, Eur J Heart Fail. 14(10):1104-11, 2012. PMID: 22740510 DOI: 10.1093/eurjhf/hfs102
  28. Marom O., Nakhoul F., Tisch U., Shiban A., Abassi Z., and Haick H. Gold Nanoparticle Sensors for Detecting Chronic Kidney Disease and Disease Progression. Nanomedicine-Future Medicine,;7(5):639-50, 2012. PMID: 22401266 DOI: 10.2217/nnm.11.135
  29. Abu-Saleh N., Ovcharenko E., Awad H., Goltsman I., Khamaisi M., Hoffman A., Heyman SN, Winaver J., Abassi1 Z. Involvement of the endothelin and nitric oxide systems in the pathogenesis of renal ischemic damage in an experimental diabetic model. Life Sciences, 91(13-14):669-75, 2012. PMID: 22365956 DOI: 10.1016/j.lfs.2012.02.002
  30. Ramadan R, Faour D., Awad H., Khatib E., Cohen R, Yahai A., Torgovicky R., Cohen R, Lazari D, Kawachi H, Abassi Z. Early Treatment with Everolimus Exerts Nephroprotective Effect in Rats with Adriamycin-Induced Nephrotic Syndrome. Nephrology Dialysis and Transplantation, 27(6):2231-41, 2012. PMID: 22036940 DOI: 10.1093/ndt/gfr581
  31. Hofman C., Rosenthal T., Winaver J., Rubinstein I., Ramadan R., Stern N., Limor R., Awad H., and Abassi Z. Renal and Systemic Effects of Endothelin-1 in Diabetic-Hypertensive rats.  Clin Exp Hypertens. 33(7):444-54, 2011. PMID: 21932990 DOI: 10.3109/10641963.2010.549270
  32. Abassi Z, Barac YD, Kostin S, Roguin A, Ovcharenko E, Awad H, Blank A, Bar-Am O, Amit, T, Schaper J, Youdim M, Binah O. TVP1022 attenuates cardiac remodeling and kidney dysfunction in experimental volume overload-induced congestive heart failure. Circ Heart Fail. 4(4):463-73, 2011. PMID: 21558446 DOI: 10.1161/CIRCHEARTFAILURE.111.961037
  33. Goltsman I, Wang X, Lavallie ER, Diblasio-Smith EA, Ovcharenko E, Hoffman A, Abassi Z, Feuerstein GZ, Winaver J. Effects of chronic rosiglitazone treatment on renal handling of salt and water in rats with volume-overload congestive heart failure. Circ Heart Fail. 4(3):345-54, 2011. PMID: 21398416 DOI: 10.1161/CIRCHEARTFAILURE.110.960179
  34. Bishara B.., Abu-Saleh N., Awad H., Goltsman I., Ramadan R., Khamaysi I, and  Abassi Z.  Pneumoperitoneum Aggravates Renal Function in Decompensated, But Not Compensated Experimental Congestive Heart Failure: Role of Nitric Oxide. J Urol. 186(1):310-7, 2011. PMID: 21600609 DOI: 10.1016/j.juro.2011.03.040
  35. Wang X, Liu X, Zhan Y, Lavallie ER, Diblasio-Smith L, Collins-Racie L, Mounts WM, Rutkowski JL, Xu X, Goltsman I, Abassi Z, Winaver J, Feuerstein GZ. Pharmacogenomic, physiological, and biochemical investigations on safety and efficacy biomarkers associated with the peroxisome proliferator-activated receptor-gamma activator rosiglitazone in rodents: a translational medicine investigation. J. Pharmacol Exp Ther. 334(3):820-9, 2010. PMID: 20519551 DOI: 10.1124/jpet.110.167635
  36. Ovcharenko E, Hansen MK, Goltsman I, Abu-Saleh N, Abassi Z, Walsh K, Miele G, Feuerstein GZ, Winaver J. Peroxisome proliferator-activated receptor alpha and alpha/gamma agonists do not cause impairment in renal function in the rat. Nephron Physiol. 115(3): 21-30, 2010. PMID: 20460939 DOI: 10.1159/000314541
  37. Hamed S, Brenner B, Abassi Z, Aharon A, Daoud D, Roguin A. Hyperglycemia and Oxidized-LDL exert a deleterious effect on Endothelial Progenitor Cell migration in Type 2 Diabetes Mellitus. Thromb Res. 126(3):166-74, 2010. PMID: 20347119 DOI: 10.1016/j.thromres.2010.03.002
  38. Bishara B., Ramadan R, Karram T., Awad H., Abu-Saleh N, Winaver J, Assadi A., and Abassi Z. Nitric oxide synthase inhibition aggravates the adverse renal effects of high, but not low, intra-abdominal pressure. Surg Endosc. 24:826–833, 2010. PMID: 19707822 DOI: 10.1007/s00464-009-0672-3
  39. Karram T., Khamaisi M., Bishara B., Ramadan R., Nitecki S., Ben-Izhak O., Meretyk S., Winaver J., Heyman S. N., Hoffman A., Abassi Z. Urinary excretion of endothelin receptors ETA and ETB in hypertensive patients and normotensive subjects. Kidney Blood Press Res. 32(4):293-303, 2009. PMID: 19797914 DOI: 10.1159/000243053
  40. Haick H, Hakim M, Patrascu M, Levenberg C, Shehada N, Nakhoul F, Abassi Z. Sniffing Chronic Renal Failure in Rat Model by an Array of Random Networks of Single-Walled Carbon Nanotubes. ACS Nano. 26;3:1258-66, 2009. PMID: 19397334 DOI: 10.1021/nn9001775
  41. Khamaisi M, Dahan R, Hamed S, Abassi Z, Heyman SN, Raz I. Role of protein kinase C in the expression of endothelin converting enzyme-1. Endocrinology.2009, 150: 1440-9. PMID: 18974277 DOI: 10.1210/en.2008-0524
  42. Rubinstein I, Abassi Z., Milman F, Ovcharenko E, Coleman R, Winaver J, and Better OS. Hyperbaric oxygen treatment improves GFR in rats with ischemia/reperfusion renal injury: a possible role for the antioxidant/oxidant balance in the ischemic kidney. Nephrol. Dial. Transplant, 24: 428-436, 2009. PMID: 18799609 PMCID: PMC2639336 DOI: 10.1093/ndt/gfn511
  43. Bishara B., Karram T., Khatib S., Ramadan R., Schwartz H. , Hoffman A., and Abassi Z. Impact of Pneumoperitoneum on Renal Perfusion and Excretory Function: Beneficial Effects of Nitroglycerine. Surg Endosc. 23(3):568-76, 2009. PMID: 18363060 DOI: 10.1007/s00464-008-9881-4
  44. Elkouby-Naor L, Abassi Z, Lagziel A, Gow A, Ben-Yosef T. Double gene deletion reveals lack of cooperation between claudin 11 and claudin 14 tight junction proteins. Cell Tissue Res. 333(3):427-38, 2008. PMID: 18663477 PMCID: PMC2943968 DOI: 10.1007/s00441-008-0621-9
  45. Reisner Y, Meiry G, Zeevi-Levin N, Barac DY, Reiter I, Abassi Z, Ziv N, Kostin S, Shaper J, Rosen MR, Binah O. Impulse conduction and gap junctional remodeling by endothelin-1 in cultured neonatal rat ventricular myocytes. J Cell Mol Med. J Cell Mol Med. 13(3):562-73, 2009. PMID: 19374685 PMCID: PMC2864006 DOI: 10.1111/j.1582-4934.2008.00361.x
  46. Asleh R, Blum S, Kalet-Litman S, Alsheik J, Miller-Lotan R, Asaf R, Rock W, Aviram M, Milman U, Shapira C, Abassi Z, Levy AP. Correction of HDL dysfunction in individuals with Diabetes and the Haptoglobin 2-2 genotype. Diabetes 57(10):2794-800, 2008. PMID: 18599520 PMCID: PMC2551691 DOI: 10.2337/db08-0450
  47. Bishara B, Shiekh H, Karram T, Rubinstein I, Azzam Z, Abu-Saleh N, Nitecki S, Winaver J, Hoffman A, Abassi Z. Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure. J Pharmacol Exp Ther.;326(2):414-22, 2008. PMID: 18467593 DOI: 10.1124/jpet.108.137745
  48. Khamaisi M, Raz I, Shilo V, Shina A, Rosenberger C, Dahan R, Abassi Z, Meidan R, Lecht S, Heyman SN. Diabetes and radiocontrast media increase endothelin converting enzyme-1 in the kidney. Kidney Int.;74(1):91-100, 2008. PMID: 18385664 DOI: 10.1038/ki.2008.112
  49. Abassi Z., Bishara B., Karram T., Khatib S., Winaver J., and Hoffman A.. Adverse effects of pneumoperitoneum on renal function: Involvement of the endothelin and nitric oxide systems. Am J Physiol: Regul Integr Comp Physiol 294: R842-R850, 2008. PMID: 18160528 DOI: 10.1152/ajpregu.00691.2007
  50. Nakhoul F., Khankin E., Yaccob A., Kawachi H. , Karram T, Awad H., Nakhoul N, Hoffman A., and Abassi Z. Eplerenone potentiates the anti-proteinuric effects of enalapril in experimental nephrotic syndrome. Am J Physiol: Renal Physiol. 294(3):F628-37, 2008. PMID: 18094029 DOI: 10.1152/ajprenal.00524.2007
  51. Rosenberger C, Khamaisi M, Abassi Z., Shilo V, Weksler-Zangen S, Goldfarb M, Shina A, Zibertrest F, Eckardt KU, Rosen S, Heyman SN. Adaptation to hypoxia in the diabetic rat kidney. Kidney Int. 73(1):34-42, 2008. PMID: 17914354 DOI: 10.1038/sj.ki.5002567
  52. Goldfarb M, Rosenberger C, Abassi Z., Shina A, Zilbersat F, Eckardt KU, Rosen S, Heyman SN. Acute-on-chronic renal failure in the rat: functional compensation and hypoxia tolerance. Am J Nephrol. 26 (1):22-33, 2006. PMID: 16508244 DOI: 10.1159/000091783
  53. Azzam ZS, Adir Y, Welch L, Chen J, Winaver J, Factor P, Krivoy N, Hoffman A, Sznajder JI, Abassi Z. Alveolar fluid reabsorption is increased in rats with compensated heart failure. Am J Physiol: Lung Cell Mol Physiol. 291(5):L1094-100, 2006. PMID: 16815890 DOI: 10.1152/ajplung.00180.2005
  54. Ovcharenko E, Abassi Z, Rubinstein I, Kaballa A, Hoffman A, and Winaver J. Renal effects of human urotensin-II in rats with experimental congestive heart failure. Nephrol. Dial. Transplant. 21: 1205-1211; 2006. PMID: 16396970 DOI: 10.1093/ndt/gfk049
  55. Winaver J, Ovcharenko E, Rubinstein I, Gurbanov K, Pollesello P, Bishara B, Hoffman A, Abassi Z. Involvement of Rho-kinase pathway in the mechanism of renal vasoconstriction and cardiac hypertrophy in rats with experimental heart failure. Am J Physiol: Heart Circ Physiol 290: H2007-H2014, 2006. PMID: 16361369 DOI: 10.1152/ajpheart.00600.2005
  56. Karram T, Hoffman A, Bishara B, Brodsky S, Golomb E, Winaver J, Abassi Z. Induction of cardiac hypertrophy by a controlled reproducible sutureless aortocaval shunt in the mouse. J Invest Surg.; 18(6):325-34, 2005. PMID: 16319054 DOI: 10.1080/08941930500328839
  57. Keidar S, Gamliel-Lazarovich A, Kaplan M, Pavlotzky E, Hamoud S, Hayek T, Karry R, Abassi Z. Mineralocorticoid Receptor Blocker Increases Angiotensin-Converting Enzyme 2 Activity in Congestive Heart Failure Patients. Circ Res. 97:946-53, 2005. PMID: 16179584 DOI: 10.1161/01.RES.0000187500.24964.7A
  58. Nakhoul F, Ramadan R, Khankin E, Yaccob A, Kositch Z, Lewin M, Assady S, and Abassi Z. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of anti-proteinuric therapies. Am J Physiol Renal Physiol. 289:F880-90, 2005. PMID: 15942045 DOI: 10.1152/ajprenal.00451.2004
  59. Karram T, Abbasi A, Keidar S, Golomb E, Hochberg I, Winaver J, Hoffman A, Abassi Z. Effects of Spironolactone and Eprosartan on Cardiac Remodeling and Angiotensin Converting Enzyme Isoforms in Rats with Experimental Heart Failure. Am J Physiol Heart Circ Physiol. 289:H1351-8, 2005. PMID: 15894569 DOI: 10.1152/ajpheart.01186.2004
  60. Nakhoul F, Yigla M, Gilman R, Reisner S A, Abassi Z. The pathogenesis of pulmonary hypertension in hemodialysis patients via arterio-venous access. Nephrology Dialysis and Transplantation. Nephrol. Dial. Transplant. 20: 1686-1692, 2005. PMID: 15840664 DOI: 10.1093/ndt/gfh840
  61. Hoffman C., Francis BN, Rosenthal T,  Winaver J,  Rubinstein I, and Abassi Z. Effects of Endothelin-1 on Systemic and Renal Hemodynamics in Hypertensive-Diabetic Rats (CRDH), Diabetic Rats (CDR), and Hypertensive Rats (SHR). J. Cardiovasc. Pharmacol. 44 (Suppl 1): S191-S194, 2004. PMID: 15838276
  62. Francis B.N., Winaver J., Karram T., Hoffman A., and Abassi Z. Renal and Systemic Effects of Chronic Blockade of ETA or ETB Receptors in Normal Rats and Animals with Experimental Heart Failure. J. Cardiovasc. Pharmacol. 44 (Suppl 1): S54- S58, 2004. PMID: 15838359
  63. Francis B.N., Abassi Z., Heyman S., Winaver J., and Hoffman A. Differential Regulation of ETA and ETB in the Renal Tissue of Rats with Compensated and Decompensated Heart Failure. J. Cardiovasc. Pharmacol. 44 (Suppl 1): S362- S365, 2004. PMID: 15838321
  64. Abassi Z., Yahia A, Zeid S, Karram T, Golomb E, Winaver J, Hoffman A. Cardiac and renal effects of omapatrilat, a vasopeptidase inhibitor, in rats with experimental congestive heart Failure. Am J Physiol Heart Circ Physiol. 288(2):H722-8, 2005. PMID: 15498826 DOI: 10.1152/ajpheart.00737.2004
  65. Fattal I, Abassi Z, Ovcharenko E, Shimada K, Takahashi M, Hoffman A, and Winaver J. Effect of dietary sodium intake on the expression of endothelin converting enzyme in the renal medulla. Nephron, 98:89-96, 2004. PMID: 15627797 DOI: 10.1159/000081557
  66. Abassi Z., Binah O, Youdim MB. Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline. Br J Pharmacol 143:371-8, 2004. PMID: 15339864 PMCID: PMC1575354 DOI: 10.1038/sj.bjp.0705962
  67. Roguin A, Nitecki S, Rubinstein I, Nevo E, Avivi A, Levy NS, Abassi Z., Sabo E, Lache O, Frank M, Hoffman A, Levy AP. Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb model. Cardiovasc Diabetol. 2:18-22, 2003. PMID: 14683529 PMCID: PMC320491 DOI: 10.1186/1475-2840-2-18
  68. Roguin A, Avivi A, Nitecki S, Rubinstein I, Levy NS, Abassi Z., Resnick MB, Lache O, Melamed-Frank M, Joel A, Hoffman A, Nevo E, Levy AP. Restoration of blood flow by using continuous perimuscular infiltration of plasmid DNA encoding subterranean mole rat Spalax ehrenbergi VEGF. Proc Natl Acad Sci U S A; 100:4644-8, 2003. PMID: 12672967 PMCID: PMC153609 DOI: 10.1073/pnas.0330833100
  69. Abassi, Z., Francis, B., Wessale, J., Ovcharenko, E., Winaver, J., and Hoffman, A.: Effects of endothelin receptors ETA and ETB blockade on renal haemodynamics in normal rats and in rats with experimental congestive heart failure. Clin. Sci. (Lond.) 103(Suppl. 48):245S-248S, 2002 [checked in PubMed]. PMID: 12193096 DOI: 10.1042/CS103S245S
  70. Gealekman, O., Abassi, Z., Rubinstein, I., Winaver, J., and Binah, O.: Role of myocardial inducible nitric oxide synthase in contractile dysfunction and b-adrenergic hypo responsiveness in rats with experimental volume-overload heart failure. Circulation 105:236-243, 2002 [checked in PubMed]. PMID: 11790707
  71. Bialik, G.M., Abassi, Z., Hammel, I., Winaver, J., and Lewinson, D.: Evaluation of atrial natriuretic peptide and brain natriuretic peptide in atrial granules of rats with experimental congestive heart failure. J. Histochem. Cytochem. 49:1293-1300, 2001 [checked in PubMed]. PMID: 11561014 DOI: 10.1177/002215540104901012
  72. Abassi, Z., Brodsky, S., Karram, T., Dobkin, I., Winaver, J., and Hoffman, A.: Temporal changes in natriuretic and antinatriuretic systems after closure of a large arteriovenous fistula. Cardiovasc. Res. 15:567-576, 2001 [checked in PubMed]. PMID: 11476747
  73. Goldfarb, M., Abassi, Z., Rosen, S., Shina, A., Brezis, M., and Heyman, S.N.: Compensated heart failure predisposes to outer medullary tubular injury: studies in rats. Kidney Int. 60:607-613, 2001 [checked in PubMed]. PMID: 11473643 DOI: 10.1046/j.1523-1755.2001.060002607.x
  74. Abassi, Z., Brodsky, S., Gealekman, O., Rubinstein, I., Hoffman, A., and Winaver, J.: Intrarenal expression and distribution of cyclooxygenase isoforms in rats with experimental heart failure. Am. J. Physiol. Renal Physiol. 280:F43-F53, 2001 [checked in PubMed]. PMID: 11133513 DOI: 10.1152/ajprenal.2001.280.1.F43
  75. Brodsky, S., Abassi, Z., Wessale, J., Ramadan, R., Winaver, J., and Hoffman, A.: Effects of A-192621.1, a specific endothelin-B antagonist, on intrarenal hemodynamic responses to endothelin-1. J. Cardiovasc. Pharmacol. 36(Suppl. 1):S311-S313, 2000 [checked in PubMed]. PMID: 11078406
  76. Green, J., Assady, S., Nakhoul, F., Bick, T., Jakopi, P., and Abassi, Z.: Differential effects of sera from normotensive and hypertensive pregnant women on Ca2+ metabolism in normal vascular smooth muscle cells. J. Am. Soc. Nephrol. 11:1188-1198, 2000 [checked in PubMed]. PMID: 10864574
  77. Hoffman, A., Abassi, Z., Brodsky, S., Ramadan, R., and Winaver, J.: Mechanisms of big endothelin-1-induced diuresis and natriuresis: role of ETB receptors. Hypertension 35:732-739, 2000 [checked in PubMed]. PMID: 10720587
  78. Brodsky, S., Gurbanov, K., Abassi, Z., Hoffman, A., Ruffolo, R.R., Jr., Feuerstein, G.Z., and Winaver, J.: Effects of eprosartan on renal function and cardiac hypertrophy in rats with experimental heart failure. Hypertension 32:746-752, 1998 [checked in PubMed]. PMID: 9774374
  79. Abassi, Z., Winaver, J., Rubinstein, I., Shimada, K., Takahashi, M., Tanzawa, K., and Hoffman, A.: Renal endothelin-converting enzyme in rats with congestive heart failure. J. Cardiovasc. Pharmacol. 31(Suppl. 1):S31-S34, 1998 [checked in PubMed]. PMID: 9595392
  80. Abassi, Z., Gurbanov, K., Rubinstein, I., Better, O.S., Hoffman, A., and Winaver, J.: Regulation of intrarenal blood flow in experimental heart failure: role of endothelin and nitric oxide. Am. J. Physiol. 274:F766-F774, 1998 [checked in PubMed]. PMID: 9575902
  81. Rubinstein I., Abassi Z., Coleman R., Milman F., Winaver J., and Better O.S.: Involvement of nitric oxide system in experimental muscle crush injury. J. Clin. Invest. 101:1325-1333, 1998 [checked in PubMed]. PMID: 9502774 PMCID: PMC508687 DOI: 10.1172/JCI810
  82. Abassi, Z.A., Gurbanov., K., Mulroney, S.E., Potlog, C., Opgenorth, T.J., Hoffman, A., Haramati, A., and Winaver, J.: Impaired nitric oxide-mediated renal vasodilation in rats with experimental heart failure: role of angiotensin II. Circulation 96:3655-3664, 1997 [checked in PubMed]. PMID: 9396468
  83. Abassi, Z., Kotob, S., Pieruzzi, F., Abouassali, M., Keiser, H.R., Fratantoni, J.C., and Alayash, A.I.: Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats. J. Lab. Clin. Med. 129:603-610, 1997 [checked in PubMed]. [This manuscript received an editorial comment: J. Lab. Clin. Med. 129:580-583, 1997.] PMID: 9178726
  84. Gurbanov, K., Rubinstein, I., Hoffman, A., Abassi, Z., Better, O.S., and Winaver, J.: Differential regulation of renal regional blood flow by endothelin-1. Am. J. Physiol. 271:F1166-F1172, 1996 [checked in PubMed]. PMID: 8997390 DOI: 10.1152/ajprenal.1996.271.6.F1166
  85. Gurbanov, K., Rubinstein, I., Hoffman, A., Abassi, Z., Better, O.S., and Winaver, J.: Bosentan improves renal regional blood flow in rats with experimental congestive heart failure. Eur. J. Pharmacol. 310:193-196, 1996 [checked in PubMed]. PMID: 8884216
  86. Abassi, Z., Pieruzzi, F., Nakhoul, F., and Keiser, H.R.: Effects of cyclosporine A on the synthesis, excretion, and metabolism of endothelin in the rat. Hypertension 27:1140-1148, 1996 [checked in PubMed]. PMID: 8621208
  87. Klein, H., Abassi Z., and Keiser, H.R.: Effects of angiotensin II and phenylephrine on urinary endothelin in normal female volunteers. Metabolism 44:115-118, 1995. PMID: 7854155
  88. Pieruzzi, F., Abassi, Z., and Keiser, H.R.: Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation 92:3105-3112, 1995 [checked in PubMed]. PMID: 7586282
  89. Abassi, Z., Kotob, S., Golomb, E., Pieruzzi, F., and Keiser, H.R.: Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure. Hypertension 25:1178-1184, 1995 [checked in PubMed]. PMID: 7768560
  90. Golomb, E., Abassi, Z., Cuda, G., Stylianou, M., Panchal, V.R., Trachewsky, D., and Keiser, H.R: Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats. Am. J. Physiol. 267:H1496-H1506, 1994 [checked in PubMed]. PMID: 7524366 DOI: 10.1152/ajpheart.1994.267.4.H1496
  91. Abassi, Z., Golomb E., Agbaria R., Roller P.P., Tate J., and Keiser, H.R.: Hydrolysis of iodine labelled urodilatin by recombinant neutral endopeptidase EC. 3.4.24.11. Br. J. Pharmacol. 113:204-208, 1994 [checked in PubMed]. PMID: 7812611 PMCID: PMC1510039
  92. Abassi, Z., Kelly, G., Golomb, E., Klein, H., Keiser, H.R.: Losartan improves the natriuretic response to ANF in rats with high-output heart failure. J. Pharmacol Exp. Ther. 268:224-230, 1994 [checked in PubMed]. PMID: 8301562
  93. Abassi, Z., Golomb, E., Bridenbaugh, R., and Keiser, H.R.: Metabolism of endothelin-1 and big endothelin-1 by recombinant neutral endopeptidase EC.3.4.24.11. Br. J. Pharmacol. 109:1024-1028, 1993 [checked in PubMed]. PMID: 8401914 PMCID: PMC2175735
  94. Golomb, E., Friedman, E., Abassi, Z., Trachewsky, D., and Keiser, H.R.: Rare renal transcription of the atrial natriuretic factor gene in rats. Demonstration by polymerase chain reaction. Am. J. Hypertens. 6:867-872, 1993 [checked in PubMed]. PMID: 8267943
  95. Abassi, Z., Klein, H., Cox, J., and Keiser, H.R.: Bradykinin does not modulate the natriuretic response to atrial natriuretic factor in rats with aortocaval fistula. Hypertension 21:966-970, 1993 [checked in PubMed]. PMID: 8505108
  96. Abassi, Z., Klein H., Golomb E. and Keiser H.R.: Regulation of the urinary excretion of endothelin in the rat. Am. J. Hypertens. 6:453-457, 1993 [checked in PubMed]. PMID: 8343226
  97. Abassi, Z., Tate, J., Hunsberger, S., Klein, H., Trachewsky, D., and Keiser, H.R.: Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition. Am. J. Physiol. 263:E870-E876, 1992 [checked PubMed]. PMID: 1443119 DOI: 10.1152/ajpendo.1992.263.5.E870
  98. Abassi, Z., Tate, J.E., Golomb, E., and Keiser, H.R.: Role of neutral endopeptidase in the metabolism of endothelin. Hypertension 20:89-95, 1992 [checked in PubMed]. PMID: 1618556
  99. Abassi, Z., Golomb, E., and Keiser, H.R.: Neutral endopeptidase inhibition increases the urinary excretion and plasma levels of endothelin. Metabolism 41:683-685, 1992 [checked in PubMed]. PMID: 1535677
  100. Abassi, Z., Powell, J.R., Golomb, E., and Keiser, H.R.: Renal and systemic effects of urodilatin in rats with high-output heart failure. Am. J. Physiol. 262:F615-F621, 1992 [checked in PubMed]. PMID: 1533100 DOI: 10.1152/ajprenal.1992.262.4.F615
  101. Abassi, Z., Shuranyi, E., Better, O.S., and Winaver, J.: Effect of atrial natriuretic factor on renal cGMP production in rats with adriamycin-induced nephrotic syndrome. J. Am. Soc. Nephrol. 2:1538-1544, 1992 [checked in PubMed]. PMID: 1318109
  102. Abassi, Z., Burnett, J.C., Jr., Grushka, E., Hoffman, A., Haramati, A., and Winaver, J.: Atrial natriuretic peptide and renal cGMP in rats with experimental heart failure. Am. J. Physiol. 261:R858-R864, 1991 [checked in PubMed]. PMID: 1656791 DOI: 10.1152/ajpregu.1991.261.4.R858
  103. Better, O.S., Zinman, C., Reis, D.N., Har-Shai, Y., Rubinstein, I., and Abassi, Z.: Hypertonic mannitol ameliorates intracompartmental tamponade in model compartment syndrome in the dog. Nephron 58:344-346, 1991 [checked in PubMed]. PMID: 1910155 DOI: 10.1159/000186448
  104. Abassi, Z., Haramati, A., Hoffman, A., Burnett, J.C., Jr., and Winaver, J.: Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure. Am. J. Physiol. 259:R84-R89, 1990 [checked in PubMed]. PMID: 2142862 DOI: 10.1152/ajpregu.1990.259.1.R84

Clinical Research (human subjects)

  1. Gorelik Y, Darawshi S, Yaseen H, Abassi Z, Heyman SN, Khamaisi M. Acute Renal Failure Following Near-Drowning. Kidney Int. Reports, 2018. PMID: 29989059 PMCID: PMC6035158 DOI: 10.1016/j.ekir.2018.02.007
  2. Hellou E, Bahouth Z, Sabo E, Abassi Z, Nativ O. The impact of comorbidities, sex and age on the occurrence of acute kidney injury among patients undergoing nephron-sparing surgery. Ther Adv Urol. 2018 Jan 8;10(3):103-108. PMID: 29662540 PMCID: PMC5896859 DOI: 10.1177/1756287217747190
  3. Wattad M, Darawsha W, Solomonica A, Hijazi M, Kaplan M, Makhoul BF, Abassi Z, Azzam ZS, Aronson D. Interaction Between Worsening Renal Function and Persistent Congestion in Acute Decompensated Heart Failure. Am J Cardiol. 1;115(7):932-7, 2015. PMID: 25700802 DOI: 10.1016/j.amjcard.2015.01.019
  4. Aronson D, Darawsha W, Promyslovsky M, Kaplan M, Abassi Z, Makhoul BF, Goldberg A, Azzam ZS. Hyponatraemia predicts the acute (type 1) cardio-renal syndrome. Eur J Heart Fail. 16(1):49-55, 2014. PMID: 23883652 DOI: 10.1093/eurjhf/hft123
  5. Armaly Z, Haj S, Bowirrat A, Alhaj M, Jabbour A, Fahoum Y, Abassi Z. Acute kidney injury following isotretinoin treatment. Am J Case Rep.;14:554-6, 2013. PMID: 24392180 PMCID: PMC3879014 DOI: 10.12659/AJCR.889693
  6. Schwarz, H, Abassi Z, Nitecki S, Karram T, Engel A, Ofer A, and Hoffman A. Thrombolytic Therapy in Ischemic Limbs: Is it a Worthwhile Therapeutic Option? International Journal of Angiology.14:15-21; 2005. DOI:10.1007/s00547-005-1071-9
  7. Nakhoul F., Abassi, Z., Michaeal M., Khankin E. Post-Splenectomy pseudohyperkalemia in a patient with chronic idiopathic myelofibrosis and thrombocytosis–A Case Report. Clin. Nephrol. 64:243-6, 2005. PMID: 16175953
  8. Nakhoul F, Abassi Z, Plawner M, Khankin E, Ramadan R, Lanir N, Brenner B, Green J. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients. Isr Med Assoc J. 6:213-7, 2004. PMID: 15115259
  9. Yigla M, Nakhoul F, Sabag A, Tov N, Gorevich B, Abassi Z, Reisner SA. Pulmonary hypertension in patients with end-stage renal disease. Chest. 123(5):1577-8, 22003. PMID: 12740276
  10. Nakhoul, F., Green, J., Abassi, Z., and Carter, A.: Tumor lysis syndrome induced by fludarabine monophosphate: A case report [Letter]. Eur. J. Haematol. 56:254-255, 1996 [checked in PubMed]. PMID: 8641396

Review Papers

  1. Armaly Z, Jadaon JE, Jabbour A and Abassi ZA. Preeclampsia: Novel Mechanisms and Potential Therapeutic Approaches. Front. Physiol. 2018; 9:973-988. doi: 10.3389/fphys.2018.00973. PMID: 30090069 PMCID: PMC6068263 DOI: 10.3389/fphys.2018.00973
  2. Szalat A, Perlman A, Muszkat M, Khamaisi M, Abassi Z, Heyman SN. Can SGLT2 Inhibitors Cause Acute Renal Failure? Plausible Role for Altered Glomerular Hemodynamics and Medullary Hypoxia. Drug Saf. 2018 Mar;41(3):239-252. PMID: 28952138 DOI: 10.1007/s40264-017-0602-6
  3. Azzam ZS, Kinaneh S, Bahouth F, Ismael-Badarneh R, Khoury E, Abassi Z. Involvement of Cytokines in the Pathogenesis of Salt and Water Imbalance in Congestive Heart Failure. Front Immunol.;8:716, 2017. PMID: 28674538 PMCID: PMC5474564 DOI: 10.3389/fimmu.2017.00716
  4. Goltsman I, Khoury EE, Winaver J, Abassi Z. Does Thiazolidinedione therapy exacerbate fluid retention in congestive heart failure? Pharmacol Ther. 168:75-97, 2016. PMID: 27598860 DOI: 10.1016/j.pharmthera.2016.09.007
  5. Abassi Z, Armaly Z. Phosphodiesterase-5 inhibitors: emerging nephroprotective drugs. Anatol J Cardiol. 15(4):311-2, 2015. PMID: 25880290 PMCID: PMC5336840 DOI: 10.5152/akd.2015.15072
  6. Armaly Z., Assady S., and Abassi Z.: Corin: a new player in the regulation of salt–water balance and blood pressure. Curr Opin Nephrol Hypertens, 22:713–722, 2013. PMID: 24100222 DOI: 10.1097/01.mnh.0000435609.35789.32
  7. Abassi Z., Sagi O., Armaly Z., Bishara B.: NAGL: A Novel Biomarker for Acute Kidney Injury. Harefuah, 150:111-116; 2011. PMID: 22164937
  8. Better O, and Abassi Z. Early fluid resuscitation in patients with rhabdomyolysis and impending acute kidney injury. Nat Rev Nephrol. 7(7):416-22, 2011. PMID: 21587227 DOI: 10.1038/nrneph.2011.56
  9. Abassi Z., Goltsman I., Karram T., Winaver J., and Hofman A., Aorto-caval fistula in rat: A unique model of volume-overload congestive heart failure and cardiac hypertrophy. J Biomed Biotechnol. 2011:729497, 2011. PMID: 21274403 PMCID: PMC3025398 DOI: 10.1155/2011/729497
  10. Abassi Z, Winaver J, Feuerstein GZ. The biochemical pharmacology of renin inhibitors: Implications for translational medicine in hypertension, diabetic nephropathy and heart failure: Expectations and reality. Biochem Pharmacol.;78(8):933-40, 2009. PMID: 19477166 DOI: 10.1016/j.bcp.2009.05.018
  11. Abassi Z, Armaly Z, Nakhoul F, Hoffman A. Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension. Harefuah.;147:536-42, 2008. PMID: 18693632
  12. Hochberg I, Abassi Z, Azzam ZS. Patterns of alveolar fluid clearance in heart failure. Int J Cardiol.;130(2):125-30, 2008. PMID: 18579236 DOI: 10.1016/j.ijcard.2008.03.015
  13. Abbasi A., Ramadan R, Hoffman A, and Abassi Z. Kidney-Ear Axis. Isr Med Assoc J, 9: 814-818; 2007. PMID: 18085042
  14. Blum S, Nakhoul F, Khankin E, Abassi Z. Renal slit diaphragm–the open zipper and the failing heart. Isr Med Assoc J; 9:107-11, 2007. PMID: 17348483
  15. Yigla M., Abassi Z., Reisner S.A., Nakhoul F. Pulmonary hypertension in hemodialysis patients: an unrecognized threat. Seminars in Dialysis. 19:353-358; 2006. PMID: 16970730 DOI: 10.1111/j.1525-139X.2006.00186.x
  16. Abassi Z., Nakhoul F., Khankin E., Reisner S. A., and Yigla M. Pulmonary hypertension in chronic dialysis patients with arteriovenous fistula: pathogenesis and therapeutic prospective. Curr Opin Nephrol Hypertens. 15:353-360; 2006. PMID: 16775448 DOI: 10.1097/01.mnh.0000232874.27846.37
  17. Abassi Z., Bishara B., Yaccob A., Hoffman A.. Vasopressin V2 receptor antagonists: Pharmacological properties and clinical implications. Harefuah. 144:875-880, 2005. PMID: 16400790
  18. Abassi Z., Karram T., Ellahham S., Winaver J., and Hoffman A. Implications of the Natriuretic Peptide System in the Pathogenesis of Heart Failure: Diagnostic and Therapeutic Importance. Pharmacology and Therapeutics. 102:223-241, 2004. [Invited and reviewed]. PMID: 15246247 DOI: 10.1016/j.pharmthera.2004.04.004
  19. Abassi Z., Ramadan R., Schwartz H., Hoffman A. Therapeutic implications of endothelin antagonists for cardiovascular diseases. Harefuah 143:47-53, 2004. PMID: 14748289
  20. Abassi Z, Winaver J, and Hoffman A. LARGE A-V FISTULA: PATHOPHYSIOLOGICAL CONSEQUENCES AND THERAPEUTIC PERSPECTIVES. Current Vascular Pharmacology, 1:347-354, 2003. PMID: 15320481
  21. Karram, T., Hoffman, A., Abbasi, A., and Abassi, Z.: Aldosterone—classic and non-classic effects. Harefuah 141:544-541, 2002 (in Hebrew) [checked in PubMed]. PMID: 12119772
  22. Abassi, Z.A., Ellahham, S., Winaver, J., and Hoffman, A.: The intrarenal endothelin system and hypertension. News Physiol. Sci. 16:152-156, 2001 [checked in PubMed]. [Invited and reviewed]. PMID: 11479363
  23. Ellahham, S.H., Charlon, V., Abassi, Z., Calis, K.A., and Choucair, W.K.: Bosentan and the endothelin system in congestive heart failure. Clin. Cardiol. 23:803-807, 2000 [checked in PubMed]. (Invited and reviewed). PMID: 11097125
  24. Abassi, Z., Hoffman, A., and Nakhoul, F.: Aquaporins (water channels): physiology and pathophysiology. Harefuah 138:488-494, 2000 (in Hebrew) [checked in PubMed]. PMID: 10883166
  25. Abassi, Z., Hoffman, A., and Better, O.S.: Acute renal failure complicating muscle crush injury. Semin. Nephrol. 18:558-565, 1998 [checked in PubMed]. PMID: 9754609
  26. Winaver, J., Hoffman, A., Abassi, Z., and Haramati, A.: Does the heart’s ANP help in congestive heart failure? News Physiol. Sci. 10:247-253, 1995 [not checked; not in Medline]. [Invited and reviewed]. doi.org/10.1152/physiologyonline.1995.10.6.247
  27. Abassi, Z., Klein, H., Golomb, E., and Keiser, H.R.: Urinary endothelin: a possible biological marker of renal damage. Am. J. Hypertens. 6:1046-1054, 1993 [checked in PubMed]. PMID: 8136095
  28. Abassi, Z., Klein H., Cox, J., and Keiser, H.R.: Urodilatin: a new hormone of renal origin. Cardiovasc. Drug Rev. 10:199-210, 1992 [not checked; not in Medline].
  29. Abassi, Z., Winaver, J., Hoffman, A., and Better, O.S.: Endothelin: a new vasoconstrictor of endothelial origin. Harefuah 120:388-392, 1991 (in Hebrew) [checked in PubMed]. PMID: 1879789
  30. Better, O.S., Abassi, Z., Rubinstein, I., Marom, S., Winaver, J., and Silbermann, M.: The mechanism of muscle injury in the crush syndrome: ischemic versus pressure-stretch myopathy. Miner. Electrolyte Metab. 16:181-184, 1990 [checked in PubMed]. PMID: 2277600
  31. Abassi, Z., Winaver, J., Gery, R., and Better, O.S.: Pathophysiology of atrial peptides actions. Harefuah 118:31-36, 1990 (in Hebrew) [checked in PubMed]. PMID: 2137424
  32. Abassi, Z. and Winaver, J.: Atrial natriuretic factor (ANF)—physiological aspects. Harefuah 115:296-300, 1988 (in Hebrew) [checked in PubMed]. PMID: 2976724

Invited Chapters in Books

  1. Skorecki, K., Winaver, J. Abassi, Z.: Control of extracellular fluid volume and pathophysiology of edema formation. In The Kidney, 8th edition, edited by B. Brenner. Philadelphia: W. B. Saunders, 2008, chapter 19, pp. 398-458.
  2. Winaver J., Abassi Z.: Role of neuropeptide Y in the regulation of kidney function. EXS. (95):123-32; 2006.
  3. Abassi, Z., Winaver, J., and Skorecki, K.: Control of extracellular fluid volume and pathophysiology of edema formation. In The Kidney, 7th edition, edited by B. Brenner. Philadelphia: W. B. Saunders, 2003, chapter 19, pp. 777-855.
  4. Green, J., Abassi, Z., Winaver, J., and Skorecki, K.L. Acute renal failure: clinical aspects and pathophysiologic aspects. In The Kidney: Physiology and Pathophysiology, 3rd edition, edited by D. Seldin and G. Giebisch. Philadelphia: Lippincott Williams & Wilkins, 2000, chapter 84, pp. 2329-2373.
  5. Winaver, J., Behr, T.M., and Abassi, Z. Role of chemokines in the pathogenesis of congestive heart failure. In Inflammation and Cardiac Diseases, series editor M.J. Parnham. Basal: Birkhäuser Verlag AG, 2003, pp. 351-367.
  6. Winaver, J., Abassi, Z., Green, J., and Skorecki, K. Control of extracellular fluid volume and pathophysiology of edema formation. In The Kidney, 6th edition, edited by B. Brenner. Philadelphia: W. B. Saunders, 1999, chapter 19, pp. 795-865.

Letters to the Editor/Editorial Comment

  1. Heyman SN, Khamaisi M, Abassi ZA. Interacting Hypoxia and Endothelin in the Diabetic Kidney: Therapeutic Options. Am J Physiol Renal Physiol. 2018 Jan 3. PMID: 29357427 DOI: 10.1152/ajprenal.00598.2017
  2. Heyman SN, Khamaisi M, Rosenberger C, Szalat A, Abassi Z. Increased Hematocrit During Sodium-Glucose Cotransporter-2 Inhibitor Therapy. J Clin Med Res. 9(2):176-177, 2017. PMCID: PMC5215022 PMID: 28090234 DOI: 10.14740/jocmr2849w
  3. Heyman SN, Khamaisi M, Rosen S, Rosenberger C, Abassi Z. Potential Hypoxic Renal Injury in Patients With Diabetes on SGLT2 Inhibitors: Caution Regarding Concomitant Use of NSAIDs and Iodinated Contrast Media. Diabetes Care. 40(4):e40-e41, 2017. PMID: 28130255 DOI: 10.2337/dc16-2200
  4. Abassi Z. and Armaly Z.: Phosphodiesterase-5 inhibitors: Emerging nephroprotective drugs. Anatol J Cardiol  15: 311-312, 2015. PMID: 25880290 PMCID: PMC5336840 DOI: 10.5152/akd.2015.15072
  5. Abassi Z.: Review of book Atrial Natriuretic Factor, edited by A.D. Struthers (Oxford: Blackwell, 1990; 256 pp.) Cardiovasc. Res. 27: 2287-2288, 1993.
  6. Hoffman, A., Grossman, E., Abassi, Z., and Keiser. H.R.: Renal endothelin and hypertension [Letter; comment on Nature 368:703-710, 1994]. Nature 372:50, 1994 [checked in PubMed and Medline]. PMID: 7818710 DOI: 10.1038/372050a0